Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy
Crossref DOI link: https://doi.org/10.1038/onc.2015.329
Published Online: 2015-09-14
Published Print: 2016-05-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mandal, R
Becker, S
Strebhardt, K
Text and Data Mining valid from 2015-09-14
Version of Record valid from 2015-09-14
Article History
Received: 3 July 2015
Revised: 27 July 2015
Accepted: 27 July 2015
First Online: 14 September 2015
Competing interests
: The authors declare no conflict of interest.